Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: InforMax Taps Amersham Exec to Be President, Chairman, and CEO

This update adds background to the original article.

NEW YORK, March 13 - InforMax has named Andrew Whiteley president, chairman, and CEO, the company announced late on Wednesday.

Whiteley takes over from Alex Titomirov, the company's founder, who is resigning from the company immediately, InforMax said in a statement.

InforMax has scheduled a conference call for Thursday at 8:45 a.m. Eastern time to discuss the move.

As GenomeWeb reported in October, Titomirov left his post, and COO James Bernstein, another founder, retired.
Titomirov said at the time that he will step down as CEO as soon as InforMax finds a replacement. Titomirov also said he will remain chairman of the board, but that option was killed in Thursday's announcement.

The recruiting company Heidrick & Struggles was brought in to recruit the new executive, which the company said it hoped to do by the first quarter 2002.

It was right on time. Whiteley, who has sat on InforMax's board since 2000, was previously president of Amersham Biosciences' bioinformatics division.

"Over the next few months, I anticipate working closely with our current and future customers, collaboration partners, management team and employees as we execute and enhance InforMax's business," Whiteley said in the statement.
Bernstein retired as president, COO, and the board of directors on Dec. 31. John Green, executive vice president and CFO of the Bethesda, Md.-based bioinformatics company, assumed COO duties.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.